Group One Trading’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
Other funds holding TAK
Group One Trading's TAK Position: Q3 2026 in Review
Group One Trading sold out of Takeda Pharmaceutical (TAK) in Q3 2026, closing a stake of 34,035 shares — an estimated $603K sold.
Group One Trading first reported a position in TAK in Q1 2019 and held it in 12 quarters. The position peaked at $754K in Q2 2022. 396 funds tracked by Wall St. Rank hold TAK as of Q3 2026.
- Group One Trading reported no remaining Takeda Pharmaceutical position as of Q3 2026 after selling out during the quarter.
- Group One Trading sold 34,035 Takeda Pharmaceutical shares in Q3 2026, an estimated $603K.
- Group One Trading first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 12 quarters.
- Group One Trading's Takeda Pharmaceutical position peaked at $754K in Q2 2022.
- 396 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2026.
Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.